Diabetes

‘Modest’ benefit for post-MI T2D glucose monitoring

October 20, 2020

COVID-19 antibody response not reduced with diabetes

October 20, 2020

Recall widens for diabetes drug metformin

October 16, 2020

Diabetes

T2D treatments create tension between glycemic and cardiovascular goals

October 12, 2020

Evaluation of Glycemic Control and Cost Savings Associated With Liraglutide Dose Reduction at a Veterans Affairs Hospital

October 7, 2020

Diabetes

PPIs associated with diabetes risk, but questions remain

October 6, 2020

Diabetes

Time to screen for liver disease in type 2 diabetes?

October 5, 2020

Diabetes

Dapagliflozin’s CKD performance sends heart failure messages

October 5, 2020

AHA scientific statement highlights cardiorenal benefit of new diabetes drugs

October 1, 2020

Geriatric patients: My three rules for them

October 1, 2020

Higher glycemic time in range may benefit T2D patients

September 28, 2020

Exercise cuts diabetes death risk by a third in two studies

September 28, 2020

Once-weekly insulin data published; could alter treatment

September 23, 2020

Diabetes

Vascular dementia risk particularly high in type 2 diabetes

September 23, 2020

‘Dose response’ between exercise and improvement in diabetes

September 21, 2020

Diabetes